Envision Ocular, LLC (01027)

Clinical research site in Bloomfield, New Jersey

As of July 2026, 1 paid clinical trial is recruiting at Envision Ocular, LLC (01027) in Bloomfield, New Jersey. Active studies at this site focus on Geographic Atrophy Secondary to Age-related Macular Degeneration alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .

New trial at Envision Ocular, LLC (01027)? We'll email you when one opens.

Recruiting clinical trials at Envision Ocular, LLC (01027) (1)

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for Geographic Atrophy Secondary to Age-related Macular Degeneration
78 locations incl. Gilbert
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All·Age: 60+
Code: NCT07215390·Phase 2·Recruiting·Listed Oct 2025
Apply to this trial

Get new-trial alerts for Envision Ocular, LLC (01027)

We'll email you whenever a new clinical trial starts recruiting at this research site in Bloomfield, NJ. Unsubscribe anytime.

More research sites in Bloomfield

Is this your research site?

This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.

Explore more

Paid clinical trials in Bloomfield, NJ · New Jersey clinical trials